{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:06:23Z","timestamp":1790795183139,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2018GSF118071"],"award-info":[{"award-number":["2018GSF118071"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2018GSF118025"],"award-info":[{"award-number":["2018GSF118025"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperhomocysteinemia is associated with autoimmune diseases such as ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). Current findings regarding plasma\/serum homocysteine (HCY) levels in AS patients are inconsistent. This study aims to systematically evaluate the association between circulating HCY levels and AS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Online electronic databases (PubMed, Web of Science, Embase, ScienceDirect, China National Knowledge Infrastructure (CNKI), and Wanfang data) were used to retrieve all relevant articles published up to May 7, 2020. The pooled standardized mean difference (SMD) with 95% confidence interval (CI) was calculated using the random-effect model, Stata16 software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nine articles containing 778 AS patients and 522 controls were included in this meta-analysis. No significant differences in HCY levels were found between AS and control groups (pooled SMD\u2009=\u20090.46, 95% CI\u2009=\u2009\u2212\u20090.30 to 1.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.23). However, subgroup analysis suggested that HCY levels were significantly higher (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) in the AS group treated with methotrexate (MTX) compared with the control group. In contrast, HCY levels were significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) lower in the AS group receiving anti-TNF-\u03b1 treatment compared with the control group. No significant differences were detected between HCY levels and disease activity scores (Bath AS disease activity index, BASDAI), and methylenetetrahydrofolate reductase (MTHFR) C677T genotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This meta-analysis indicates that HCY levels are similar between AS and controls, and do not correlate with disease activity. However, different medical treatments cause fluctuations of circulating HCY levels in AS patients. Further and larger-scale studies are needed to confirm these findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This study was registered at international prospective register of systematic reviews (PROSPERO), registration number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020184426\">CRD42020184426<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-021-00175-7","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T12:03:23Z","timestamp":1615377803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of homocysteine with ankylosing spondylitis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"61","author":[{"given":"Hui-hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-tao","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-2908","authenticated-orcid":false,"given":"Ying-jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"8","key":"175_CR1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"J Braun","year":"2005","unstructured":"Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52(8):2447\u201351.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"175_CR2","first-page":"2283","volume":"28","author":"S Brophy","year":"2001","unstructured":"Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001;28(10):2283\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"175_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/art.1780370105","volume":"37","author":"M Leirisalo-Repo","year":"1994","unstructured":"Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Sepp\u00e4l\u00e4 K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994;37(1):23\u201331.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"175_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.rti.0000139405.51472.7a","volume":"19","author":"AS Souza Jr","year":"2004","unstructured":"Souza AS Jr, M\u00fcller NL, Marchiori E, Soares-Souza LV, de Souza Rocha M. Pulmonary abnormalities in ankylosing spondylitis: inspiratory and expiratory high-resolution CT findings in 17 patients. J Thorac Imaging. 2004;19(4):259\u201363.","journal-title":"J Thorac Imaging"},{"issue":"2","key":"175_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10067-003-0845-8","volume":"23","author":"A El Maghraoui","year":"2004","unstructured":"El Maghraoui A, Chaouir S, Abid A, Bezza A, Tabache F, Achemlal L, et al. Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol. 2004;23(2):123\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"175_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s42358-018-0040-x","volume":"58","author":"AY Shimabuco","year":"2018","unstructured":"Shimabuco AY, Gon\u00e7alves CR, Moraes JCB, Waisberg MG, Ribeiro ACM, Sampaio-Barros PD, et al. Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors. Adv Rheumatol. 2018;58(1):40.","journal-title":"Adv Rheumatol"},{"issue":"3","key":"175_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004;34(3):585\u201392.","journal-title":"Semin Arthritis Rheum"},{"key":"175_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12986-017-0233-z","volume":"14","author":"A Kumar","year":"2017","unstructured":"Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017;14:78.","journal-title":"Nutr Metab (Lond)"},{"issue":"3","key":"175_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12291-013-0373-5","volume":"29","author":"V Shenoy","year":"2014","unstructured":"Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity of coronary artery disease. Indian J Clin Biochem. 2014;29(3):339\u201344.","journal-title":"Indian J Clin Biochem"},{"issue":"16","key":"175_CR10","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Jama. 2002;288(16):2015\u201322.","journal-title":"Jama"},{"issue":"7","key":"175_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1056\/NEJM200202143460702","volume":"346","author":"J Loscalzo","year":"2002","unstructured":"Loscalzo J. Homocysteine and dementias. N Engl J Med. 2002;346(7):466\u20138.","journal-title":"N Engl J Med"},{"issue":"12","key":"175_CR12","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1515\/CCLM.2007.362","volume":"45","author":"M Herrmann","year":"2007","unstructured":"Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. The role of hyperhomocysteinemia as well as folate, vitamin B (6) and B (12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med. 2007;45(12):1621\u201332.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"175_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000444900","volume":"2","author":"Y Long","year":"2016","unstructured":"Long Y, Nie J. Homocysteine in Renal Injury. Kidney Dis (Basel). 2016;2(2):80\u20137.","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"175_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/nu11020383","volume":"11","author":"I Capelli","year":"2019","unstructured":"Capelli I, Cianciolo G, Gasperoni L, Zappulo F, Tondolo F, Cappuccilli M, et al. Folic acid and vitamin B12 administration in CKD, why not? Nutrients. 2019;11(2):383.","journal-title":"Nutrients"},{"issue":"6","key":"175_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s10067-020-04985-w","volume":"39","author":"NB Sam","year":"2020","unstructured":"Sam NB, Zhang Q, Li BZ, Li XM, Wang DG, Pan HF, et al. Serum\/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol. 2020;39(6):1725\u201336.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"175_CR16","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1007\/s10067-020-05093-5","volume":"39","author":"J Shu","year":"2020","unstructured":"Shu J, Sun X, Li J, Li F, Tang J, Shi L. Serum homocysteine levels and their association with clinical characteristics of inflammatory arthritis. Clin Rheumatol. 2020;39(11):3295\u2013302.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"175_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ibd.20309","volume":"14","author":"JM Phelip","year":"2008","unstructured":"Phelip JM, Ducros V, Faucheron JL, Flourie B, Roblin X. Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(2):242\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"175_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","volume":"190","author":"M Wakkee","year":"2007","unstructured":"Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190(1):1\u20139.","journal-title":"Atherosclerosis."},{"issue":"5","key":"175_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/clpt.1989.179","volume":"46","author":"H Refsum","year":"1989","unstructured":"Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther. 1989;46(5):510\u201320.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"175_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.autrev.2007.03.008","volume":"6","author":"PE Lazzerini","year":"2007","unstructured":"Lazzerini PE, Capecchi PL, Selvi E, Lorenzini S, Bisogno S, Galeazzi M, et al. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev. 2007;6(7):503\u20139.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"175_CR21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/eji.1830260707","volume":"26","author":"XM Gao","year":"1996","unstructured":"Gao XM, Wordsworth P, McMichael AJ, Kyaw MM, Seifert M, Rees D, et al. Homocysteine modification of HLA antigens and its immunological consequences. Eur J Immunol. 1996;26(7):1443\u201350.","journal-title":"Eur J Immunol"},{"issue":"3","key":"175_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/biom10030393","volume":"10","author":"NM Elsherbiny","year":"2020","unstructured":"Elsherbiny NM, Sharma I, Kira D, Alhusban S, Samra YA, Jadeja R, et al. Homocysteine induces inflammation in retina and brain. Biomolecules. 2020;10(3):393.","journal-title":"Biomolecules"},{"issue":"1","key":"175_CR23","first-page":"371","volume":"21","author":"S Wang","year":"2020","unstructured":"Wang S, Huang Z, Li W, He S, Wu H, Zhu J, et al. IL-37 expression is decreased in patients with hyperhomocysteinemia and protects cells from inflammatory injury by homocysteine. Mol Med Rep. 2020;21(1):371\u20138.","journal-title":"Mol Med Rep"},{"issue":"4","key":"175_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mcn.2012.03.001","volume":"49","author":"M Pirchl","year":"2012","unstructured":"Pirchl M, Ullrich C, Sperner-Unterweger B, Humpel C. Homocysteine has anti-inflammatory properties in a hypercholesterolemic rat model in vivo. Mol Cell Neurosci. 2012;49(4):456\u201363.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"175_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42358-019-0059-7","volume":"59","author":"M Morimoto","year":"2019","unstructured":"Morimoto M, Shivappa N, de Souza GP, Martini LA, Schuch NJ, Hebert JR, et al. Lack of association between dietary inflammatory index and low impact fractures in the Brazilian population: the Brazilian osteoporosis study (BRAZOS). Adv Rheumatol. 2019;59(1):16.","journal-title":"Adv Rheumatol."},{"issue":"10","key":"175_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1161\/CIRCRESAHA.112.270520","volume":"111","author":"Z Liu","year":"2012","unstructured":"Liu Z, Luo H, Zhang L, Huang Y, Liu B, Ma K, et al. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circ Res. 2012;111(10):1261\u201373.","journal-title":"Circ Res"},{"issue":"10","key":"175_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.nut.2005.01.011","volume":"21","author":"SJ Su","year":"2005","unstructured":"Su SJ, Huang LW, Pai LS, Liu HW, Chang KL. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition. 2005;21(10):994\u20131002.","journal-title":"Nutrition"},{"issue":"1\u20132","key":"175_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cccn.2003.09.003","volume":"338","author":"K Schroecksnadel","year":"2003","unstructured":"Schroecksnadel K, Frick B, Kaser S, Wirleitner B, Ledochowski M, Mur E, et al. Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Clin Chim Acta. 2003;338(1\u20132):157\u201364.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"175_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/01.RES.0000108264.67601.2C","volume":"94","author":"KK Au-Yeung","year":"2004","unstructured":"Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL, O K. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res. 2004;94(1):28\u201336.","journal-title":"Circ Res"},{"issue":"Pt 3","key":"175_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/bj3520817","volume":"352 Pt 3","author":"G Wang","year":"2000","unstructured":"Wang G, Siow YL, O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J. 2000;352 Pt 3(Pt 3):817\u201326.","journal-title":"Biochem J"},{"issue":"6","key":"175_CR31","doi-asserted-by":"publisher","first-page":"H2840","DOI":"10.1152\/ajpheart.2001.280.6.H2840","volume":"280","author":"G Wang","year":"2001","unstructured":"Wang G, Siow YL, O K. Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages. Am J Physiol Heart Circ Physiol. 2001;280(6):H2840\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"175_CR32","doi-asserted-by":"publisher","first-page":"e13871","DOI":"10.1111\/dth.13871","volume":"33","author":"Y Singh","year":"2020","unstructured":"Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan DK, et al. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol Ther. 2020;33:e13871.","journal-title":"Dermatol Ther"},{"issue":"6","key":"175_CR33","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.3390\/ijms160612560","volume":"16","author":"JJ Li","year":"2015","unstructured":"Li JJ, Li Q, Du HP, Wang YL, You SJ, Wang F, et al. Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter. Int J Mol Sci. 2015;16(6):12560\u201377.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"175_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5606\/tjr.2012.029","volume":"27","author":"N Mao","year":"2012","unstructured":"Mao N, Chen JW, Peng WF, Chen LX, Xie X. The relationship of plasma homocysteine levels and the methylenetetrahydrofolate reductase C677T gene polymorphism to Ankylosing spondylitis in a Chinese population. Turk J Rheumatol. 2012;27(3):174\u20138.","journal-title":"Turk J Rheumatol"},{"issue":"12","key":"175_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00296-009-0875-x","volume":"29","author":"BM Baskan","year":"2009","unstructured":"Baskan BM, Sivas F, Aktekin LA, Dogan YP, Ozoran K, Bodur H. Serum homocysteine level in patients with ankylosing spondylitis. Rheumatol Int. 2009;29(12):1435\u20139.","journal-title":"Rheumatol Int"},{"issue":"12","key":"175_CR36","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00296-008-0687-4","volume":"28","author":"L Gonzalez-Lopez","year":"2008","unstructured":"Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, et al. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int. 2008;28(12):1223\u20138.","journal-title":"Rheumatol Int"},{"issue":"5","key":"175_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10067-006-0396-x","volume":"26","author":"JC Wei","year":"2007","unstructured":"Wei JC, Jan MS, Yu CT, Huang YC, Yang CC, Tsou HK, et al. Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26(5):739\u201342.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"175_CR38","first-page":"111","volume":"44","author":"XY Xu","year":"2005","unstructured":"Xu XY, Zhou WH, Xiao CS, Li XF, Wang LY. A clinical study of hyperhomocysteinemia in rheumatological diseases. Zhonghua Nei Ke Za Zhi. 2005;44(2):111\u20134.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"175_CR39","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00296-012-2552-8","volume":"33","author":"M Ge\u00e7ene","year":"2013","unstructured":"Ge\u00e7ene M, Tuncay F, Borman P, Y\u00fccel D, Senes M, Y\u0131lmaz BK. Atherosclerosis in male patients with ankylosing spondylitis: the relation with methylenetetrahydrofolate reductase (C677T) gene polymorphism and plasma homocysteine levels. Rheumatol Int. 2013;33(6):1519\u201324.","journal-title":"Rheumatol Int"},{"issue":"8","key":"175_CR40","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00296-011-1972-1","volume":"32","author":"E Capkin","year":"2012","unstructured":"Capkin E, Karkucak M, Aky\u00fcz A, Alver A, Turkyilmaz AK, Zengin E. The relationship between plasma homocysteine level and different treatment modalities in patients with ankylosing spondylitis. Rheumatol Int. 2012;32(8):2349\u201353.","journal-title":"Rheumatol Int"},{"issue":"5","key":"175_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2007","unstructured":"Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26(5):710\u20134.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"175_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361\u20138.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"175_CR43","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34(10):1218\u201327.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"175_CR44","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286\u201391.","journal-title":"J Rheumatol"},{"issue":"7","key":"175_CR45","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"9","key":"175_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"175_CR47","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"175_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"175_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ."},{"key":"175_CR50","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Higgins JP, Altman DG, Group obotCSM. Analysing data and undertaking meta-analyses. Cochrane Handb Syst Rev Intervent. 2019. p. 241\u201384.","DOI":"10.1002\/9781119536604.ch10"},{"issue":"5","key":"175_CR51","first-page":"875","volume":"29","author":"S W\u00e5llberg-Jonsson","year":"2002","unstructured":"W\u00e5llberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantap\u00e4\u00e4-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol. 2002;29(5):875\u201382.","journal-title":"J Rheumatol"},{"issue":"2","key":"175_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/03009740510026922","volume":"35","author":"MA Lopez-Olivo","year":"2006","unstructured":"Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, et al. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol. 2006;35(2):112\u20136.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"175_CR53","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/ard.62.7.694","volume":"62","author":"PE Lazzerini","year":"2003","unstructured":"Lazzerini PE, Capecchi PL, Bisogno S, Galeazzi M, Marcolongo R, Pasini FL. Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis. 2003;62(7):694\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"175_CR54","first-page":"2374","volume":"31","author":"N Hornung","year":"2004","unstructured":"Hornung N, Ellingsen T, Stengaard-Pedersen K, Poulsen JH. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol. 2004;31(12):2374\u201381.","journal-title":"J Rheumatol"},{"issue":"6","key":"175_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"AE van Ede","year":"2002","unstructured":"van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2002;41(6):658\u201365.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"175_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1172\/JCI108921","volume":"61","author":"J Selhub","year":"1978","unstructured":"Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine. J Clin Invest. 1978;61(1):221\u20134.","journal-title":"J Clin Invest"},{"issue":"1","key":"175_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41398-018-0276-6","volume":"8","author":"L Wan","year":"2018","unstructured":"Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry. 2018;8(1):242.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"175_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1023\/A:1005369109055","volume":"20","author":"B Fowler","year":"1997","unstructured":"Fowler B. Disorders of homocysteine metabolism. J Inherit Metab Dis. 1997;20(2):270\u201385.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"175_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ng0694-195","volume":"7","author":"P Goyette","year":"1994","unstructured":"Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7(2):195\u2013200.","journal-title":"Nat Genet"},{"issue":"9","key":"175_CR60","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2337\/diacare.23.9.1348","volume":"23","author":"S Gallistl","year":"2000","unstructured":"Gallistl S, Sudi K, Mangge H, Erwa W, Borkenstein M. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care. 2000;23(9):1348\u201352.","journal-title":"Diabetes Care"},{"key":"175_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.","journal-title":"Nutr J"},{"issue":"1","key":"175_CR62","first-page":"32","volume":"11","author":"S Zhang","year":"2014","unstructured":"Zhang S, Bai YY, Luo LM, Xiao WK, Wu HM, Ye P. Association between serum homocysteine and arterial stiffness in elderly: a community-based study. J Geriatr Cardiol. 2014;11(1):32\u20138.","journal-title":"J Geriatr Cardiol"},{"issue":"8","key":"175_CR63","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(8):1396\u2013404.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"175_CR64","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1136\/annrheumdis-2018-213317","volume":"78","author":"S Mathieu","year":"2019","unstructured":"Mathieu S, Soubrier M. Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis. Ann Rheum Dis. 2019;78(6):e57.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"175_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"175_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/art.22094","volume":"55","author":"S Suissa","year":"2006","unstructured":"Suissa S, Bernatsky S, Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum. 2006;55(4):531\u20136.","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-021-00175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-021-00175-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-021-00175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T23:06:43Z","timestamp":1675033603000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-021-00175-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1186\/s42358-021-00175-7","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}